Symposium

[S21] The 5th current status of reverse translational research conducted by hospital pharmacists ~Drug discovery & development research based on clinical evidence~

Sun. Mar 28, 2021 1:15 PM - 3:15 PM [Room E] Oral Presentation E (Online)

Organizer: Masuda Satohiro (IUHW Narita Hosp. Dept. Pharmacy), Itoh Hiroki (Oita Univ. Hosp. Dept. Pharmacy), Ikeda Ryuji (Univ. Miyazaki Hosp. Dept. Pharmacy), Jono Hirofumi (Kumamoto Univ. Hosp. Dept. Pharmacy)

With innovative advancements in science and technology, large numbers of therapeutic target molecules have recently been identified. However, while molecular-targeted agents that modulate the function of target molecules have been widely used in clinical settings, multiple trials and errors are often necessary for proper medication due to a lack of enough clinical evidence. Therefore, clinical pharmacists are required to provide novel clinical evidence in medical settings.
In this symposium, we would like to present the latest topics about the basic and clinical research conducted by clinical pharmacists working in clinical settings, and discuss the current status of research conducted by hospital pharmacists, their issues, and future development, in order to consider the meaning and importance of research activities.

+Add all to schedule

オーガナイザー挨拶：増田智先（国際医療福祉大病院薬） (1:15 PM - 1:20 PM)

1:20 PM - 1:45 PM

[S21-1] Development of gene and nucleic acid medicines based on multi-functional biocompatible nanoparticles and application to pulmonary administration

○Yukinobu Kodama¹, Tomoaki Kurosaki¹, Hitoshi Sasaki¹ (1. Dept. of Hosp. Pharm. Nagasaki Univ. Hosp.)

1:45 PM - 2:10 PM

[S21-2] Basic and clinical research to identify therapeutic target for drug-induced nephropathy

○Shunsaku Nakagawa¹ (1. Department of Clinical Pharmacology & Therapeutics, Kyoto University Hospital)

2:10 PM - 2:35 PM

[S21-3] Reverse Translational Research for the Prevention of Adverse Effects of Cancer Drugs Using Medical Big Data

○Mitsuhiro Goda¹, Yoshito Zamami^2,3, Takahiro Niimura², Masahumi Kayano³, Hirofumi Hamano³, Naoto Okada³, Fuka Aizawa^2,3, Kenta Yagi¹, Yuki Izawa-Ishizawa⁴, Yasushi Kirino³, Toshimi Nakamura³, Keisuke Ishizawa^2,3 (1. Clin. Res. Ctr. Dev. Ther., Tokushima Univ. Hosp., 2. Tokushima Univ. Grad. Sch. of Bio. Sci., 3. Dept. of Pharmacy, Tokushima Univ. Hosp., 4. AWA Support Center, Tokushima Univ.)

2:35 PM - 3:00 PM

[S21-4] Perspective and issues raised in therapeutic drug monitoring guided by area under the concentration-time curve of vancomycin

○Kazutaka Oda², Hirofumi Jono¹, Hideyuki Saito¹ (1. Dept. of Pharm., Kumamoto Univ. Hosp., 2. Dept. of Infect. Con., Kumamoto Univ. Hosp.)

総括：伊東弘樹（大分大病院薬） (3:00 PM - 3:15 PM)

Session information